The Global Post-Traumatic Stress Injury Foundation is excited to announce that a long-accepted anesthesiology procedure called stellate ganglion block (SGB) has been verified as an effective treatment for post-traumatic stress disorder (PTSD) through positron emission tomography (PET) scans. SGB, pioneered for use in treating PTSD by our medical director Dr. Eugene Lipov, has been administered to more than 2200 patients thus far at seven military hospitals and shown a success rate greater than 70 percent.
Chicago, Illinois (PRWEB) October 27, 2015
Six doctors presented a paper Friday at the American Society of Anesthesiologists meeting in San Diego, Calif., validating the effectiveness of Stellate Ganglion Block (SGB,) through visible evidence seen on Positron Emission Tomography (PET) scans, in treating Post-Traumatic Stress Disorder (PTSD).
SGB, which has been used to relieve migraines and chronic pain since the 1920s, involves a single injection into the sympathetic nerve tissue on the right side of a cervical vertebra. The use for SGB as a treatment for PTSD was pioneered by Dr. Eugene Lipov, a Chicago-based anesthesiologist (http://www.eugenelipovmd.com), who has been featured in a number of TV appearances about his findings (http://globalptsifoundation.org/videos).
Since his first publication in 2008, a number of researchers have reported positive results for SGB use as a PTSD treatment. To date, more than 2200 SGB shots have been administered at seven military hospitals with a success rate greater than 70 percent and no long-term complications. SGB is markedly more effective than the conventional, gold-standard therapies, such as psychotropic drugs, currently being used by doctors within the military and at the Veterans Administration (VA). Current approaches are effective less than 25 percent of the time, so new therapies are desperately needed. Lipov summarized the current state of treatment for PTSD in his recent article : http://www.omicsgroup.org/journals/with-warrelated-post-traumatic-stress-disorder-being-resistant-to-pharmaceuticals-is-it-time-to-give-stellate-ganglion-block-sgb-a-shot-2167-1222-S4-020.php?aid=61076
“With the objective evidence of SGB effectiveness for PTSD patients, combined with the large number of patients already treated with more than 70% success, we are hopeful this may finally lead to the procedure being made available for veterans and other PTSD sufferers,“ said Lipov.
Eugene Lipov MD
For the original version on PRWeb visit: http://www.prweb.com/releases/GlobalPTSIFoundation/2015-01/prweb13042484.htm